Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma.
Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma.
复制标题
DOI:
10.1002/hed.21478
复制
发表时间:
2011-12
影响因子:
2.9
通讯作者:
Murphy, Barbara
中科院分区:
文献类型:
--
作者:
Chung, Christine H.;Pohlmann, Paula R.;Rothenberg, Mace L.;Burkey, Brian B.;Parker, Joel;Palka, Kevin;Aulino, Joseph;Puzanov, Igor;Murphy, Barbara
Recurrent head and neck squamous cell carcinoma (HNSCC) remains a difficult cancer to treat. Here, we describe a patient with HNSCC who had complete response to methotrexate (MTX) after progressing on multiple cytotoxic agents, cetuximab, and AMG-479 (monoclonal antibody against insulin-like growth factor-1 receptor [IGF-1R]). The clinical information was collected by a retrospective medical record review under an Institutional Review Board–approved protocol. From 4 tumors and 2 normal mucosal epithelia, global gene expression, and IGF-1R and dihydrofolate reductase (DHFR) protein levels were determined. Effective target inhibition in the tumor was confirmed by the decreased protein levels of total and phospho-IGF-1R after treatment with AMG-479. Decreased level of DHFR and conversion of a gene expression profile associated with cetuximab-resistance to cetuximab-sensitivity were also observed. This suggests that the combination of AMG- 479 and MTX or cetuximab may be a promising therapeutic approach in refractory HNSCC.
登录
查看更多内容
影响因子:
45.3
作者:
Giantonio, Bruce J.;Catalano, Paul J.;Benson, Al B., III
通讯作者:
Benson, Al B., III
影响因子:
4.8
作者:
Kuribayashi, A;Kataoka, K;Miura, M
通讯作者:
Miura, M
影响因子:
158.5
作者:
Sandler, Alan;Gray, Robert;Johnson, David H.
通讯作者:
Johnson, David H.
影响因子:
5.6
作者:
Volpato, Jordan P.;Fossati, Elena;Pelletier, Joelle N.
通讯作者:
Pelletier, Joelle N.
影响因子:
56.9
作者:
Paez, JG;Jänne, PA;Meyerson, M
通讯作者:
Meyerson, M